Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:816-817
Published online before print September 18, 2006, doi: 10.1161/01.HYP.0000240978.77934.3a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/5/816    most recent
01.HYP.0000240978.77934.3av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, B. L.
Related Collections
Right arrow Other etiology
Right arrow Other Treatment
Right arrowRelated Article

(Hypertension. 2006;48:816.)
© 2006 American Heart Association, Inc.


Editorial Commentaries

Antihypertensive Prescribing

Do We Have Reason to Celebrate?

Barry L. Carter

From the Division of Clinical and Administrative Pharmacy, College of Pharmacy, and Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Correspondence to Barry L. Carter, University of Iowa, 115 South Grand Ave, Iowa City, IA 52242. E-mail barry-carter@uiowa.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The blood pressure (BP) goal for Healthy People 2000 was to achieve BP control in 50% of the population with hypertension. Unfortunately, BP was only controlled in 31% in 2000.1 When the goal was not achieved in 2000, the same goal of 50% was established in Healthy People 2010.2 There is slightly >3 years to achieve Health People 2010. Do we have reason to be concerned with achieving this rather modest goal? One way to gauge our progress is to evaluate how well medical providers are adhering to guidelines.

There are several ways to evaluate guideline adherence, including physician surveys, chart reviews, and antihypertensive prescribing trends.3 In addition, there are many ways to evaluate prescribing, including pharmacy databases. Some pharmacy databases have significant limitations, because they only provide data in aggregate and do not provide information about therapy for specific patients. An example would be the percentage of all of the prescriptions written for ß-blockers. These studies provide information on overall prescribing trends but do not assess actual regimens being used in patients.

One of the common findings from prescribing trends demonstrates the steady decline in the use of diuretics. By the mid-1990s, most studies had found that diuretic use had declined to {approx}10% of all antihypertensive prescriptions.3 Again, it is important to recognize that this is the percentage of antihypertensive prescriptions and not that 10% of patients were receiving diuretics. Nevertheless, diuretic use dropped significantly from 1980 to 2000.

The study by Ma et al4 in this issue of . . . [Full Text of this Article]


Related Article:

Changes in Antihypertensive Prescribing During US Outpatient Visits for Uncomplicated Hypertension Between 1993 and 2004
Jun Ma, Ky-Van Lee, and Randall S. Stafford
Hypertension 2006 48: 846-852. [Abstract] [Full Text] [PDF]